top of page

Turning the Tide on Dementia


10:30am - 12:30pm Monday 3 June: Continuing Professional Development Session 1
This session is RACGP approved. 

The session will have 4 topics and will aim to inform and educate clinicians, general practitioners (GPs), geriatricians, specialist physicians, psychiatrists, and other experts on the most recent tests, therapies, trials, and practical aspects associated with the diagnosis and management of dementia.

1. Dementia and MCI diagnosis.        
2. Risk Reduction Associate.               
3. The patient journey with cognitive decline -

from Symptom Onset to Diagnosis/Management. 
4. Support of the care partner. 

1:30 - 3:30pm Monday 3 June: Continuing Professional Development Session 2
This session is RACGP approved. 

Continuing from session 1, this session will follow the same theme with 4 new speakers.


1. Driving Considerations. 
2. Deprescribing. 
3. Post Diagnostic Support. 
4. What’s on the horizon for anti-amyloid

therapies and potential risks. 

2:00 - 3:30pm Monday 3 June: Continuing Medical Education Session 1

Title: Safe and Appropriate Use of Anti Amyloid Antibodies

Introduction and overview. 

1. Appropriate Use Recommendation. 

2. How to give an infusion. 

3. How to read ARIA for Radiologists. 

4. Post Marketing Surveillance. 

CPD Approved Activity- Stacked.jpg
CPD Approved Activity- Stacked.jpg

Educator: Associate Professor Mark Yates
Educator: Associate Professor Jane Alty

Educator: Dr Stephanie Daly

Educator: Professor Dimity Pond

Educator: Prof Kaarin Anstey

Educator: Prof Sarah Hilmer

Educator: Prof Lee-Fay Low

Educator: Prof Bruce Brew

Educator: Professor Christopher

Educator: Professor Colin Masters

Educator: Dr Lavier Gomes

Educator: Prof Bruce Brew

Educator: Professor Susannah Ahern


Picture 1.jpg

Associate Professor Mark Yates 

Consultant Geriatrician, Grampians Health & Health and Clinical Associate Professor,

Deakin University

Mark is a consultant Geriatrician in the Grampians Region Cognitive, Dementia and Memory Service (CDAMS) at Grampians Health, Ballarat, Health and Clinical Associate Professor at Deakin University.


Mark is a member of the team at Grampians Health that developed the Dementia Care in Hospitals Program, which is an all of hospital education program linked to a bedside cognitive impairment alert the Cognitive Impairment Identifier. The DCHP was originally introduced into 22 Victorian hospitals. From 2015 to 2017, with grant funding from the Australian Government, the DCHP was rolled out and evaluated in four hospitals across four states and territories. It was implemented in the Northern Territory in 2019 and Queensland in 2021 at Redcliffe Hospital so now reaches of 7 of the 8 States and Territories in Australia.


He is a member of the National Dementia Reference Group and past member of the National Commission for Safety and Quality in Health Care’s Cognitive Impairment Advisory Group, the Pharmaceutical Benefits Advisory Committee and a past President of AMA Victoria.

Assoc Prof Jane Alty.jpg

Associate Professor Jane Alty      

Associate Professor of Neurology, University of Tasmania & Neurologist, Royal Hobart Hospital

Jane Alty is an Associate Professor of Neurology at the University of Tasmania and a Neurologist at the Royal Hobart Hospital. She is also Co-Director of the ISLAND Clinic, a ‘one-stop’ cognitive clinic that provides an interdisciplinary assessment and diagnosis for Tasmanian residents. She is a lead investigator on the ISLAND Project, a 10-year public health initiative to reduce dementia risk, comprising ~14,000 participants. Her research investigates Artificial Intelligence methods to detect the preclinical stages of Alzheimer’s and Parkinson’s disease, funded through the NHMRC.  She qualified from the University of Cambridge and completed general medicine and neurology training in the north of England. She undertook a movement disorders fellowship at Monash Medical Centre and was awarded an MD by the University of York for research evaluating computer technologies in neurodegenerative disorders. Her research contributed to a new spin out company, ClearSky Medical Diagnostics, that produces precision tools for clinical trials.

Stephanie Daly.jpg

Dr Stephanie Daly            

General Practitioner, Golden Grove

Dr Stephanie Daly is  a GP in Adelaide, originally from the UK and has been working in Adelaide for four years.  Dr Stephanie Daly works as a contractor GP in Golden Grove three days a week. She has a strong interest in older persons' health in particular dementia and cognition, as well as health throughout the lifecourse of women. Dr Stephanie Daly is participating in research to better understand the importance of public health campaigns in improving awareness of dementia and cognitive impairment.  She is a lead GP educator with Dementia Training Australia, providing educational resources and workshops across Australia. Dr Daly is also the founder of Sensus Cognition a GP led community clinic for cognition and dementia support and assessment.

Dimity Pond.jpg

Professor Dimity Pond          

General Practitioner, Berowra, NSW

Dimity Pond is a GP in clinical practice in Berowra, NSW. She has Honorary Professor positions at Western Sydney, Tasmania, and the University of New England. Her research has been mainly in the field of aged care, in particular dementia. It focusses on improving care for older people, including medications and transitional care. She has recently been the clinical lead for a Northern Sydney Primary Health Network project for GPs around Quality Improvement in Dementia Care.


Professor Kaarin Anstey       

ARC Laureate Fellow and Director, UNSW Ageing Futures Institute

Kaarin Anstey is an ARC Laureate Fellow and Director of the UNSW Ageing Futures Institute. She is also a conjoint Senior Principal Research Scientist at Neuroscience Research Australia. Anstey’s research focuses on improving brain health and dementia risk reduction through the development and implementation of assessments and interventions using epidemiology and randomised controlled trials. Anstey also leads a program of work into older driver safety that focusses on the link between cognitive and sensory ageing and driving which has led to validated risk assessments and interventions to promote older driver safety. Anstey is a member of the World Dementia Council and is a member of the Governance Committee of the Global Council on Brain Health.

Sarah Hilmer Headshot.tif

Professor Sarah Hilmer         

Head of the Department of Clinical Pharmacology and Senior Staff Specialist in Aged Care, Royal North Shore Hospital

Sarah Hilmer (BScMed(Hons) MBBS(Hons) FRACP PhD) is the head of the department of Clinical Pharmacology and a senior staff specialist in Aged Care at Royal North Shore Hospital. She is a Conjoint Professor of Geriatric Pharmacology at The University of Sydney.  She is a fellow of the Australian Academy of Health and Medical Scientists (FAHMS).  She was awarded a Member of the Order of Australia (AM) for her service to clinical and geriatric pharmacology in 2022.  Hilmer’s translational research program in Ageing and Pharmacology at the Kolling Institute includes basic, clinical and population studies to understand the effects of medications and of deprescribing in ageing and frailty.  Her clinical, research, education and policy work all aim to improve outcomes of medications for older people. 

Lee-Fay Low 2_2023.JPG

Professor Lee Fay Low       

Professor in Ageing and Health, University of Sydney

Lee-Fay Low (BSc Psych (Hons), PhD) is Professor in Ageing and Health, University of Sydney. She is a registered psychologist with a PhD in psychiatric epidemiology.

Prof Low conducts research that she hopes will make a difference in the world.

Her knowledge expertise is in rehabilitation and post-diagnostic support for people with dementia, timely diagnosis of dementia, stigma and dementia literacy, community and aged care and people from culturally and linguistically diverse backgrounds. She has methodological skills in the design of complex interventions, implementation methods, population studies, systematic reviews and clustered randomised trials.

She has authored over 150 peer-reviewed articles, and three books on dementia. She is an active advocate for improving how older people are included and treated. Lee-Fay is enthusiastic about research, and even admits to liking statistics.

brew photo 2021.jpg

Professor Bruce Brew              

Professor of Medicine (Neurology), University of New South Wales & University of Notre Dame

Bruce Brew is a physician scientist who is Professor of Medicine (Neurology) at the University of New South Wales and University of Notre Dame, Director of the Peter Duncan Neurosciences Unit and the Neurosciences Program St Vincent’s Centre for Applied Medical Research and neurologist at St Vincent’s Hospital Sydney. He has a long standing interest in dementia at both basic science and clinical levels. He has been conducting trials in Alzheimer’s disease for approximately 25 years. He has written over 400 papers and four books and over 20,000-30,000 citations (Scopus-Google Scholar). He has been on numerous international scientific committees and serves on the editorial boards of several journals. He has been a reviewer for NIH as well as other national funding bodies in various countries. In 2015 he was awarded an Order of Australia for his services to Neurology.

Michael Woodward.jpg

Associate Professor Michael Woodward        

Head of Aged Care Research and Memory Clinic, Austin Health, Heidelberg, VIC

Associate Professor Michael Woodward is Head of Aged Care Research and the Memory Clinic at Austin Health in Melbourne, Victoria. He is a specialist in geriatric medicine with major interests in the treatment of Alzheimer’s disease (AD) and other dementias. He is Principal Investigator for numerous research trials of new therapies for AD and related disorders. He is Board member of the national Dementia Australia Research Foundation, as well as one of the 3 Honorary Medical Advisors to Dementia Australia.

He was awarded his MD on the overlap between the dementia syndromes and how memory clinic data bases contribute to our understanding of the dementias. More recent research interests have focussed on characterizing the frontal (dysexecutive) variant of Alzheimer’s Disease.

He is Chair of the (adult) Training Accreditation Subcommittee of the RACP and has been extensively involved with training bodies of the College and the ANZSGM for over 30 years.

On Australia Day 2016 he was honoured with the award of Membership of the Order of Australia (AM) for his work in dementia and geriatric medicine, his contribution to these numerous professional bodies and his body of publications and other writings.

bottom of page